Circulating Tumor Cells (CTCs) in Smoldering and Active Multiple Myeloma (MM): Mechanism of Egression, Clinical Significance and Therapeutic Endpoints

被引:8
作者
Garces, Juan-Jose [1 ]
Puig, Noemi [2 ]
Termin, Rosalinda [3 ]
Teresa Cedena, Maria [4 ]
Moreno, Cristina [5 ]
Perez, Jose J. [6 ]
Alignani, Diego [7 ,8 ]
Sarai, Sarvide [9 ]
Oriol, Albert [9 ]
Gonzalez Garcia, Esther [10 ]
Escalante, Fernando [11 ]
Sureda, Anna [12 ]
De Arriba, Felipe [13 ]
Rios, Rafael [14 ]
Maria Moraleda, Jose [15 ]
Gironella, Mercedes [16 ]
Hernandez, Miguel T. [17 ]
Joan Bargay, Juan Jose [18 ]
Palomera, Luis [19 ]
Orfao, Alberto [20 ]
Terpos, Evangelos [21 ]
Perez, Albert [22 ]
Jelinkek, Tomas [23 ]
Suarez, Alexia [24 ,25 ]
Goldschmidt, Harmut [26 ]
Avet-Loiseau, Herve [27 ]
Roccaro, Aldo M. [28 ]
Martinez-Lopez, Joaquin [29 ]
Jose Lahuerta, Juan [30 ]
Ocio, Enrique [31 ]
Rosinol, Laura [32 ]
Blade Creixenti, Joan [33 ]
Mateos, Maria-Victoria [34 ]
San-Miguel, Jesus [35 ]
Paiva, Bruno [36 ,37 ]
机构
[1] Clin Univ Navarra, Ctr Invest Med Aplicada CIMA, Inst Invest Sanitaria Navarra IDISNA, Pamplona, Spain
[2] Univ Hosp Salamanca, Salamanca, Spain
[3] Univ Navarra, Clin Univ Navarra, Ctr Invest Med Aplicada, Pamplona, Spain
[4] Hosp Univ 12 Octubre, Dept Hematol, CIBERONC, Inst Invest IMAS12, Madrid, Spain
[5] Clin Univ Navarra, Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain
[6] Hosp Univ Salamanca HUSAL, IBSAL, IBMCC USAL CSIC, CIBERONC, Salamanca, Spain
[7] Clin Univ Navarra, Pamplona, Spain
[8] Inst Invest Sanitaria Navarra IdiSNA, Ctr Invest Med Aplicada, Pamplona, Spain
[9] Inst Catala Oncol LHosp, Barcelona, Spain
[10] Hosp Cabuenes, Gijon, Spain
[11] Hosp Univ Leon, Dept Hematol, Leon, Spain
[12] Univ Barcelona, IDIBELL, Inst Catala Oncol, Hospitalet,Hematol Dept, Barcelona, Spain
[13] Univ Murcia, Hosp Morales Meseguer, IMIB Arrixaca, Murcia, Spain
[14] Hosp Univ Virgen Ias Nieves Granada, Inst Invest Biosanitaria IBS GRANADA, Granada, Spain
[15] Univ Murcia, Hosp Univ Virgen Arrixaca, Murcia, Spain
[16] Univ Hosp Vall dHebron, Dept Hematol, Barcelona, Spain
[17] Hosp Univ Canarias, Dept Hematol, San Cristobal la Laguna, Spain
[18] Hosp Son Llatzer, Palma De Mallorca, Spain
[19] Hosp Clin Univ Lozano Blesa, Zaragoza, Spain
[20] Univ Salamanca, Dept Med & Cytometry Serv NUCLEUS, Canc Res Ctr IBMCC, USAL CSIC, Salamanca, Spain
[21] Biomed Res Inst Salamanca IBSAL, Salamanca, Spain
[22] Natl & Kapodistrian Univ Athens, Dept Clin Therapeut, Sch Med, Athens, Greece
[23] Hosp Univ Son Espases, Palma De Mallorca, Spain
[24] Univ Ostrava, Dept Hematooncol, Univ Hosp Ostrava, Ostrava, Czech Republic
[25] Univ Ostrava, Fac Med, Ostrava, Czech Republic
[26] Hosp Univ Gran Canaria Dr Negrin, Lla Palmas, Spain
[27] Univ Hosp Heidelberg, Heidelberg, Germany
[28] IUC T Oncopole, Unite Genom Myelome, Toulouse, France
[29] ASST Spedali Civili Brescia, Clin Res Dev & Phase Unit, Brescia, Italy
[30] Hosp Univ Salamanca, Salamanca, Spain
[31] Hosp Univ 12 Octubre, Madrid, Spain
[32] Hosp Univ Marques Valdecilla IDIVAL, Santander, Spain
[33] Hosp Clin Barcelona, Dept Hematol, IDIBAPS, Barcelona, Spain
[34] Hosp Clin Barcelona, Dept Hematol, IDIBAPS, Amyloidosis & Multiple Myeloma Unit, Barcelona, Spain
[35] Hosp Univ Salamanca Hematol, Inst Invest Biomed Salamanca IBSAL, Salamanca, Spain
[36] Clin Univ Navarra, Ctr Invest Med Aplicada CIMA, IDISNA, CIBERONC, Pamplona, Spain
[37] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain
关键词
D O I
10.1182/blood-2021-146535
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
76
引用
收藏
页数:8
相关论文
empty
未找到相关数据